聚乙二醇化干扰素α2a和α2b在原发性血小板增多症治疗中的不同疗效。 - Suppr

Suppr

超能文献

Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia.

作者信息

Noel Nicolas, Michot Jean-Marie, Besson Caroline, Goujard Cécile, Lambotte Olivier

出版信息

Int J Hematol. 2013 Mar;97(3):438-9. doi: 10.1007/s12185-013-1288-x. Epub 2013 Feb 12.

DOI:10.1007/s12185-013-1288-x

PMID:23400413

Abstract

摘要

相似文献

Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia.

Int J Hematol. 2013 Mar;97(3):438-9. doi: 10.1007/s12185-013-1288-x. Epub 2013 Feb 12.

Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.

Haematologica. 2016 May;101(5):e182-4. doi: 10.3324/haematol.2015.139691. Epub 2016 Jan 27.

Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms.

Cancer Med. 2020 Mar;9(6):2039-2051. doi: 10.1002/cam4.2741. Epub 2020 Jan 28.

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.

Ter Arkh. 2018 Aug 17;90(7):23-29. doi: 10.26442/terarkh201890723-29.

Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses.

Leukemia. 2018 Aug;32(8):1830-1833. doi: 10.1038/s41375-018-0080-6. Epub 2018 Feb 28.

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Leukemia. 2019 Dec;33(12):2974-2978. doi: 10.1038/s41375-019-0524-7. Epub 2019 Jul 30.

Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients.

Intervirology. 2010;53(3):146-53. doi: 10.1159/000274975.

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

Indian J Gastroenterol. 2011 Sep;30(5):239-40. doi: 10.1007/s12664-011-0126-4.

Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.

Br J Haematol. 2019 Aug;186(4):561-564. doi: 10.1111/bjh.15968. Epub 2019 May 15.

The "pegylated" story continues--perhaps because both ends (α2a and α2b) are true?

J Hepatol. 2012 Jul;57(1):226-8; author reply 229. doi: 10.1016/j.jhep.2012.01.026. Epub 2012 Mar 3.

本文引用的文献

Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles.

J Viral Hepat. 2012 Jan;19 Suppl 1:33-6. doi: 10.1111/j.1365-2893.2011.01519.x.

The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types.

Cytokine. 2011 Jan;53(1):52-9. doi: 10.1016/j.cyto.2010.09.006. Epub 2010 Oct 12.

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials.

Hepatology. 2010 Apr;51(4):1176-84. doi: 10.1002/hep.23504.

Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.

J Clin Oncol. 2009 Nov 10;27(32):5418-24. doi: 10.1200/JCO.2009.23.6075. Epub 2009 Oct 13.

Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.

Cancer Chemother Pharmacol. 2003 Jan;51(1):81-6. doi: 10.1007/s00280-002-0533-4. Epub 2002 Nov 21.

Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1.

Blood. 2000 Sep 15;96(6):2093-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验